Moreover, targeting c-MYC with siRNAs in platinum-resistant ovarian cancer significantly inhibits cell growth and viability, induces cell-cycle arrest and activates apoptosis in vitro, and reduces tumor growth in vivo (67). Here, MYC is linked to ovarian cancer.